PropertyValue
?:abstract
  • Coronavirus disease outbreak has affected all aspect of clinical care including cancer clinical trials In order to minimize exposure of frail cancer patients, an implementation of telemedicine was retained The impact of this implementation on primary and secondary endpoints criteria of ongoing clinical trials was analyzed Out of 128 oncology clinical trials, 25 (19%) had an implementation of teleconsultation Poor data reporting induced mainly a bias on qualitative and descriptive primary endpoints than those assessing efficacy (80% vs 20%;p < 0 001) The integration of telemedicine and E-technologies in the medical practices and clinical trials must be designed and validated
is ?:annotates of
?:creator
?:journal
  • Cancer_Investigation
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Title: Impact of COVID-19 outbreak through telemedicine implementationon data reporting during oncology clinical trials
?:type
?:who_covidence_id
  • #952507
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/no2orptp>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/no2orptp>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all